Featured Research

from universities, journals, and other organizations

Mouse Experiments Shed Light On Age Effects In Arthritis

Date:
June 15, 2009
Source:
BioMed Central
Summary:
Older mice are more susceptible to proteoglycan-induced arthritis. Researchers writing in BioMed Central's open access journal Immunity & Ageing have shown, for the first time, that young mice are completely resistant, but become fully susceptible to the disease with age.

Older mice are more susceptible to proteoglycan-induced arthritis (PGIA). Researchers have shown, for the first time, that young mice are completely resistant, but become fully susceptible to the disease with age.

Tibor Glant, from Rush University Medical Center, Chicago, worked with a team of researchers to investigate the effects of immunological senescence on susceptibility to arthritis. He said, "Our results suggest that, while the young can effectively regulate their immune response to proteoglycan, in older mice these mechanisms are partially lost. This 'physiological' loss of control may lead to sustained activation of autoreactive T cells and auto-antibody production, directing the immune system against self antigen and culminating in joint inflammation in genetically susceptible animals".

The researchers conclude that complex age-related changes in interactions between T cells and antigen presenting cells, and reduced generation of regulatory T cells, may lead to impaired immune regulation and the development of autoimmune disease. Glant said, "Increasing incidence of rheumatoid arthritis with age has been repeatedly shown in the human population, hopefully this mouse model will go some way towards explaining why".


Story Source:

The above story is based on materials provided by BioMed Central. Note: Materials may be edited for content and length.


Journal Reference:

  1. Oktavia Tarjanyi, Ferenc Boldizsar, Peter Nemeth, Katalin Mikecz and Tibor T. Glant. Age-related changes in arthritis susceptibility and severity in a murine model of rheumatoid arthritis. Immunity & Ageing, (in press) [link]

Cite This Page:

BioMed Central. "Mouse Experiments Shed Light On Age Effects In Arthritis." ScienceDaily. ScienceDaily, 15 June 2009. <www.sciencedaily.com/releases/2009/06/090610192433.htm>.
BioMed Central. (2009, June 15). Mouse Experiments Shed Light On Age Effects In Arthritis. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/06/090610192433.htm
BioMed Central. "Mouse Experiments Shed Light On Age Effects In Arthritis." ScienceDaily. www.sciencedaily.com/releases/2009/06/090610192433.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins